by Alwin L | May 4, 2026 | Mass Tort Settlements
Faster mass tort settlements aren’t just about getting defendants to “yes.” The real key is removing friction from everything that happens between intake and disbursement—especially healthcare lien resolution, data management, and client communication. When those...
by Alwin L | Apr 27, 2026 | Mass Tort Settlements
Talc litigation is moving fast in early 2026, and lien resolution has to move with it. Recent verdicts, MDL growth, and ongoing settlement efforts are changing both client expectations and the lien landscape in real time. When you update your talc strategy, you need...
by Alwin L | Nov 17, 2025 | Mass Tort Settlements
Coordinating thousands of liens in a mass tort settlement is a formidable endeavor—one that requires relentless organization, advanced technology, and deep expertise in both legal compliance and negotiation. The modern mass tort landscape includes multidistrict...
by Alwin L | Nov 10, 2025 | Mass Tort Settlements
The Depo-Provera multidistrict litigation (MDL) has quickly become one of the most closely watched pharmaceutical mass actions of the decade. Plaintiffs from across the United States have alleged that the popular contraceptive injection—manufactured by Pfizer—caused...
by Olivia Pollock | Sep 15, 2025 | Mass Tort Settlements
TDF, or tenofovir disoproxil fumarate, is a compound found in leading HIV drugs like Truvada, Viread, Atripla, Complera, and Stribild. Over the past several years, TDF litigation has taken center stage in the pharmaceutical industry, as thousands of plaintiffs have...
by Olivia Pollock | Aug 4, 2025 | Mass Tort Settlements
When it comes to mass tort settlements, the difference between a satisfied client and a disappointed one often comes down to what happens after the case “settles.” While securing a large gross settlement is an impressive feat, the true value for injured plaintiffs—and...